Original Research Article
DOI: http://dx.doi.org/10.18203/issn.2455-4510.IntJResOrthop20181439
Relationship of vitamin D, BMI and BMD in age and gender linked population
1Department of Orthopaedics, 2Department of Physiology, K. P. C Medical College and Hospital, Kolkata, West Bengal, India
Received: 07 March 2018
Revised: 30 March 2018
Accepted: 31 March 2018
*Correspondence:
Priyanka Pahari,
E-mail: priyanka.pahari@gmail.com
Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
ABSTRACT
Background: Vitamin D insufficiency prevalence has been related to low bone mineral density (BMD). However, controversial results have been reported for the relationship between serum 25-hydroxyvitamin D [25(OH)D] levels and BMD. This study was done to investigate whether serum 25(OH)D levels were associated with BMD in different age group and sex link population.
Methods: This study involved, aged 40-70 yr, who is consecutively selected from KPCMCH, BMD camp. BMD was measured at the lumbar spine and femoral neck. The correlation between serum 25(OH)D levels and BMD was investigated.
Results: Vitamin D levels for healthy and patients individuals at hospital. The age of 40 healthy subjects ranged from 40 to 70 years with the average of 55.30±10.30 years and body mass index (BMI) ranged from 18 to 37 kg/m2, with the of average of 28.90±5.20 kg/m2. Comparison between healthy and patients based on BMI and vitamin D level for the overweight BMI healthy individuals was 29.78±9.40 ng/ml, and that of hyperlipidemic patients was 24.47±8.78 ng/ml.
Conclusions: In this study, there is significant different between healthy and patients group in vitamin D3level.BMD significantly decreased in patients group more elderly.
Keywords: Vitamin D, Gender, BMI, BMD
INTRODUCTION
Vitamin D is considered essential for bone health. In some studies, vitamin D insufficiency has been reported to be associated with low bone mineral density (BMD) and increased bone loss.1,2 However, the results reported so far have been controversial.3,4 Now obesity is another rapidly growing health problem in most developed countries.2 During the last decade, the prevalence of obesity (body mass index (BMI) ≥30) increased dramatically. Vitamin D low levels negatively affect bone mineralization causing rickets in children and osteomalacia in adults.3,5 In addition, vitamin D insufficiency is associated with other diseases; chronic kidney disease (CKD) gives rise to secondary hyperparathyroidism (SHPT) which can lead to loss of bone density and elevated rates of fracture in renal patients, common cancers, autoimmune disorders, multiple sclerosis, cardiovascular disease, lung function, and asthma.6-12
METHODS
Study population
In this cross-sectional study 100 subject have been enrolled which was conducted in March 2016 in BMD camp of KPCMCH. Out of hundred subject: 40 subjects were apparently healthy and 60 subjects were selected as a patients after taking the history of inclusion criteria included: Multiple joint pain for prolong period in adult, Low back pain with kyphotic deformity in elderly age group, young patients with pain in long bones of lower limb, history of fracture with insignificant trauma.
Serum collection and analysis
Blood samples (6 ml) were collected from each subject in the morning after an overnight fast. The blood was centrifuged for 10 min at 1000 rpm to obtain serum. The serum was placed in Eppendorf tubes and stored at -80°C until used.
Measurement of vitamin D
Quantitative colorimetric immunoenzymatic determination of 25(OH) vitamin D concentrations in human plasma level was developed by using vitamin D ELISA kit (Diametra, Milano, Italy). The kit is a competitive solid phase enzyme-linked immunosorbent assay (ELISA). Samples were analyzed according to the manufacturer guidelines.
Vitamin D levels were classified into 3 major groups as follows:13,14
- 1) Sufficient (>30 ng/ml);
- 2) Insufficient (20–30 ng/ml);
- 3) Deficient (<20 ng/mL).
BMI measurements
Women were divided into six and men into five BMI groups: i) BMI <20– underweight (only for women); ii) BMI 20-24.9– normal weight; iii) BMI 25-29.9–overweight; iv) BMI 30-34.9– obesity, degree I; v) BMI 35-39.9 –obesity, degree II; vi) BMI ≥40– super obese, obesity degree III.15
Bone mineral density examination
BMD was determined using dual energy x-ray absorptiometry (DEXA). Both spine region including lumbar vertebrae 1-4 and femoral neck area l BMD were obtained. To eliminate operator differences, all women were tested by the same operator during the study
Statistical methods
Data from 100 subjects were expressed as mean±SD and statistically analyzed using SPSS v. Linear regression analysis was performed to assess correlations between BMI, serum 25(OH)D3 and 1,25(OH)2D3 levels, age and gender. P values <0.05 were considered as indicating statistical significance.
RESULTS
Table 1 summarizes the age and the body mass index (BMI) of the first group subjects (100 subjects (40–70 years) vitamin D levels for healthy and patients individuals at hospital.
Significant (p<0.050).
Subjects: The age of 40 healthy subjects ranged from 40 to 70 years with the average of 55.30±10.30 years and body mass index (BMI) ranged from 18 to 37 kg/m2, with the of average of 28.90±5.20 kg/m2 (Table 1).
Besides, the age of 60 patients ranged from 40 to 70 years, with the average of 55.89±9.39 years, and body mass index (BMI) ranged from 17 to 37 kg/m2, with the average of 28.82±4.94 kg/m2 (Table 1). Further classification is also found in Table 1.
Furthermore, Table 2 showed the differences in vitamin D levels between the healthy and patient’s subjects. A significant difference (p<0.050) was detected between healthy males (25.04±08.02 ng/ml) and females (23.55±7.74 ng/ml).
Comparison between healthy and patients based on BMI was done and vitamin D mean level for the normal BMI healthy individuals was 31.30±9.42 ng/mL, while that of patients was 27.67±10.10 ng/ml. Also, vitamin D level for the overweight BMI healthy individuals was 29.78±9.40 ng/ml, and that of hyperlipidemic patients was 24.47±8.78 ng/ml (Table 2).
DISCUSSION
In our study we found that there is a linear relationship between vitamin D, BMI and BMD. Patients with increased BMI having excess amount of body fat, which is a very good reserver of fat soluble vitamine D. So obese patients have a very high reserve and low blood concentration of vitamin D as release of vitamin D is extremely slow from body fat. So BMI adversely affects vitamin D concentration in blood.17-20
Vitamin D concentration also depends on gender, nationality, physical activity, age, lifestyle, taking particular drugs and food habits.21–24 Low vitamin D concentration in pediatric age group results in ricket (before epiphyseal fusion) and in adults it results in osteomalacia (after epiphyseal fusion). Therefore low vitamin d children results in bone pain, skeletal immaturity and various deformities, less chance of fracture healing due to low bone matrix formation.
BMD mainly depends on age, activity level, and menopause. Decrease in BMD results in kyphotic deformity of spine due to weakness of weight bearing dorsal spine. It also leads to pain, decrease in activity level and again it decrease BMD.25,26
Obesity and increase in body weight lead to more deformity and pain in low BMD patients. So obesity is responsible for low vitamin D3 and increase morbidities in senile population.
CONCLUSION
In this study there is significant different between healthy and patients group in vitamin D3 level. BMD significantly decreased in patients group more elderly.
There is significant correlation between vitamin D3 level and BMD at hip and spine. Male gender, BMI and age are significant predictor of BMD. Patients with higher BMI have significantly lower BMD. So, vitamin D3 level is adversely related with BMI. It suggests that Obesity adversely affects bone health and prone to bone fragility, bone pain and fractures.
Funding: No funding sources
Conflict of interest: None declared
Ethical approval: The study was approved by the institutional ethics committee
REFERENCES
- 1. Narula R, Tauseef M, Ahmad IA, Agarwal K, Ashok A, Anjana A. Vitamin D deficiency among postmenopausal women with osteoporosis. J Clin Diagn Res. 2013;7:336-38.
- 2. Sadat-Ali M, Al Elq AH, Al-Turki HA, Al-Mulhim FA, Al-Ali AK. Influence of vitamin D levels on bone mineral density and osteoporosis. Ann Saudi Med. 2011;31:602-8.
- 3. Wat WZ, Leung JY, Tam S, Kung AW. Prevalence and impact of vitamin D insufficiency in southern Chinese adults. Ann Nutr Metab. 2007;51:59-64.
- 4. von Mühlen DG, Greendale GA, Garland CF, Wan L, Barrett-Connor E. Vitamin D parathyroid hormone levels and bone mineral density in community-dwelling older women: the Rancho Bernardo Study. Osteoporos Int. 2005;16:1721-6.
- 5. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problemwith health consequences. Am J Clinical Nutr. 2008;87:1080–6.
- 6. Dusso AS. Kidney disease and vitamin D levels: 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, and VDR activation. Kidney Int Suppl. 2011;1(4):136–41.
- 7. Chiang KC, Yeh CN, Chen MF, Chen TC. Hepatocellular carcinoma and vitamin D: a review. J Gastroenterol Hepatol. 2011;26(11):1597-603.
- 8. Cannell JJ1, Vieth R, Umhau JC, Holick MF, Grant WB, Madronich S, et al. Epidemic influenza and vitamin D. Epidemiol Infect. 2006;134(6):1129-40.
- 9. Liu PT1, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311:1770–3.
- 10. Giovannoni G, Ebers G. Multiple sclerosis: the environment and causation. Curr Opinion Neurol. 2007;20:261–8.
- 11. Larose TL, Chen Y, Camargo CA Jr, Langhammer A, Romundstad P, Mai XM. Factors associated with vitaminD deficiency in a Norwegian population: the HUNT Study. J Epidemiol Community Health. 2014;68:165–70.
- 12. Larose TL, Langhammer A, Chen Y, Camargo CA, Romundstad P, Mai SM. Serum 25-hydroxyvitamin Dlevels and lung function in adults with asthma: the HUNT Study. Eur Resp J. 2015;45:1019–26.
- 13. Holick MF, Binkley NC, Bischoff-Ferrari HA. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metabol. 2011;96:1911–30.
- 14. Annweiler C, Allali G, Allain P. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol. 2009;16:1083–9.
- 15. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988–2004. Arch Internal Med. 2009;169:626–32.
- 16. Priyanka P, Mandal SK, Ghosh S, Maity CR, Nutrients present in hen’s and duck’s egg commonly available in the markets of West Bengal, India. Indian J Fundamental Applied Life Sci. 2011: 259-262.
- 17. Al-Daghri NM, Alkharfy KM, Al-Othman A, Yakout SM, Al-Saleh Y, Fouda MA, et al. Effect of gender, season, and vitamin D status on bone biochemical markers in Saudi diabetes patients. Molecules. 2012;17(7):8408-18.
- 18. Al-Othman A, Al-Musharaf S, Al-Daghri NM, Krishnaswamy S, Yusuf DS, Alkharfy KM, et al. Effect of physical activity and sun exposure on vitamin D status of Saudi children and adolescents. BMC Pediatrics. 2012;12:92.
- 19. Al-Othman A, Al-Musharaf S, Al-Daghri NM. Tea and coffee consumption in relation to vitamin D and calcium levels in Saudi adolescents. Nutr J. 2012;11(1):56.
- 20. Hamilton B., Grantham J, Racinais S, and Chalabi H, Vitamin D deficiency is endemic in Middle Eastern sportsmen. Public Health Nutrition. 2010;13:1528–34.
- 21. Meguid NA, Hashish A.F, Anwar M, and Sidhom G,Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitaminD in Egyptian children with autism. J Alternative Complementary Med. 2010;6:641–5.
- 22. Racinais S, Hamilton B, Li CK, Grantham J. Vitamin D and physical fitness in Qatari girls, Archives of Disease inChildhood.2010;95:854–865.
- 23. Rosenstreich SJ, Rich C, Volwiler W. Deposition in andrelease of vitamin D3 from body fat: evidence for a storage sitein the rat. J Clin Invest. 1971;50:679-87.
- 24. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr. 2000;72:690-3.
- 25. Abbasi AA, Amin M, Smiertka JK, Grunberger G, MacPherson B, Hares M, et al. Abnormalities of vitaminD and calcium metabolism after surgical treatment of morbidobesity: a study of 136 patients. Endocr Pract. 2007;13:131-6.
- 26. Carlin AM, Rao DS, Meslemani AM, Genaw JA, Parikh NJ, Levy S, et al. Prevalence of vitamin Ddepletion among morbidly obese patients seeking gastric bypass surgery. Surg Obes Relat Dis. 2006;2:98-103.